Sophia Randolph - 16 Dec 2022 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Medical Officer, Director
Signature
/s/ Peter Garcia, by power of attorney
Issuer symbol
ALXO
Transactions as of
16 Dec 2022
Net transactions value
+$189,875
Form type
4
Filing time
20 Dec 2022, 16:08:58 UTC
Previous filing
09 Aug 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Options Exercise $16,052 +8,404 +3.7% $1.91 233,800 16 Dec 2022 Direct
transaction ALXO Common Stock Options Exercise $51,942 +12,731 +5.4% $4.08 246,531 16 Dec 2022 Direct
transaction ALXO Common Stock Options Exercise $121,881 +25,339 +10% $4.81 271,870 16 Dec 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Stock Option (right to buy) Options Exercise $0 -8,404 -68% $0.000000 4,027 16 Dec 2022 Common Stock 8,404 $1.91 Direct F1
transaction ALXO Stock Option (right to buy) Options Exercise $0 -12,731 -12% $0.000000 95,175 16 Dec 2022 Common Stock 12,731 $4.08 Direct F2
transaction ALXO Stock Option (right to buy) Options Exercise $0 -25,339 -50% $0.000000 25,340 16 Dec 2022 Common Stock 25,339 $4.81 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.
F2 The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.